Event

Schedule a meeting with our scientific experts during DCAT Week.

Schedule a meeting
Press enter to search

Suggested searches

Early Development
Candidate Selection
Late Development
Tailored Services
Translational Pharmaceutics

Ask the experts

Our team of scientists are here to help you with your drug development challenges

Talk to our scientific panel

Whether your question is associated with optimizing your formulation or manufacturing process, or planning your clinical pharmacology study, we are here to help.
  • Stuart Mair - Medical Director at Quotient Sciences

    Dr Stuart Mair

    Global Vice President, Medical, Early Development

  • Andrew Lewis

    Vice President, Pharmaceutical Sciences

  • Nazim Kanji

    Executive Director, Pediatric Services

  • Asma Patel - Vice President, Integrated Development Services at Quotient Sciences

    Dr Asma Patel

    Vice President, Integrated Development Services

  • Dr Vanessa Zann - Senior Research Fellow, Biopharmaceutics & Clinical Pharmacology

    Dr Vanessa Zann

    Senior Drug Development Consultant

  • Iain Shaw - Director of 14 C Enabled Drug Development

    Iain Shaw

    Director, 14-C Enabled Drug Development

  • Alison Wilby - Director Modelling and Simulation at Quotient Sciences

    Alison Wilby

    Director of Modelling & Simulation

  • Stuart McDougall

    Vice President of BioAnalysis

  • Paul Quigley - Head of Drug Substance Production at Quotient Sciences

    Paul Quigley

    Head of Production, Drug Substance

  • Gareth Jenkins - Science and Technology Director at Quotient Sciences

    Gareth Jenkins

    VP Science and Technology, Candidate Development Services

  • Jeff Baisley

    VP, Commercial Operations, Commercial

Thank you for getting in touch with us.

We will send you a reply in the next 48 hours.
If you have not heard from us in the next 48 hours, do not hesitate to call us on:
UK +44 (0)115 974 9000 / US +1-800-769-3518

Ask questions to our scientific team

Popular questions our scientists are being asked:

How can I use clinical data in real time to make the right formulation choice? How can I ensure maximum flexibility in clinical manufacturing and batch sizes? How can I meet my clinical trial needs while reducing costs and wastage? How can I select the best formulation technology for my poorly soluble molecule?

If you are interested in volunteering

Learn more about volunteering

And finally your details

Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.
Drug Substance Formulation Development Clinical Trial Manufacturing Commercial Manufacturing Bioanalysis Clinical Pharmacology Data Sciences Drug Development Consulting
Ask us a question
We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.